Rubric Capital Management (New York)’s Passage Bio PASG Stock Holding History

Rubric Capital Management (New York)’s Portfolio PASG Stock Details PASG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-41,105	Closed	-$1.13M	–	90
2022 Q4	$1.13M	Hold	41,105	–	–	0.05%	90
2022 Q3	$1.03M	Hold	41,105	–	–	0.05%	84
2022 Q2	$1.94M	Buy	+41,105	New	+$1.92M	0.1%	80

Other funds holding PASG

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Rubric Capital Management (New York)'s PASG Position: Q1 2023 in Review

Rubric Capital Management (New York) sold out of Passage Bio (PASG) in Q1 2023, closing a stake of 41,105 shares — an estimated $1.13M sold.

Rubric Capital Management (New York) first reported a position in PASG in Q2 2022 and held it in 3 quarters. The position peaked at $1.94M in Q2 2022. 58 funds tracked by Wall St. Rank hold PASG as of Q1 2023.

Rubric Capital Management (New York) reported no remaining Passage Bio position as of Q1 2023 after selling out during the quarter.
Rubric Capital Management (New York) sold 41,105 Passage Bio shares in Q1 2023, an estimated $1.13M.
Rubric Capital Management (New York) first reported a position in Passage Bio in Q2 2022 and held it in 3 quarters.
Rubric Capital Management (New York)'s Passage Bio position peaked at $1.94M in Q2 2022.
58 funds tracked by Wall St. Rank held Passage Bio as of Q1 2023.

Based on Rubric Capital Management (New York)'s 13F filing for Q1 2023, filed 12 May 2023.